Bolt Biotherapeutics Inc. (BOLT)
0.51
-0.01 (-1.26%)
At close: Jan 15, 2025, 11:54 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 7.88M | 5.73M | 1.26M | 231.00K | 215.00K | n/a |
| Cost of Revenue | 1.88M | 4.89M | 3.67M | 40.36M | 26.00M | 302.00K |
| Gross Profit | 5.99M | 838.00K | -2.41M | -40.13M | -25.79M | -302.00K |
| Operating Income | -76.20M | -90.32M | -92.79M | -49.18M | -30.97M | -11.63M |
| Interest Income | 7.00M | 2.22M | 281.00K | 199.00K | 524.00K | 193.00K |
| Pretax Income | -69.20M | -88.10M | -98.59M | -60.73M | -30.49M | -11.59M |
| Net Income | -69.20M | -85.88M | -104.39M | -72.27M | -30.00M | -11.59M |
| Selling & General & Admin | 22.53M | 22.93M | 18.39M | 9.06M | 5.18M | 2.21M |
| Research & Development | 61.54M | 73.12M | 75.66M | 40.36M | 26.00M | 9.42M |
| Other Expenses | n/a | n/a | -6.08M | -11.74M | -42.00K | -153.00K |
| Operating Expenses | 84.07M | 96.05M | 94.05M | 49.41M | 31.18M | 11.63M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 84.07M | 96.05M | 94.05M | 49.41M | 31.18M | 11.63M |
| Income Tax | n/a | -2.22M | 5.80M | 11.55M | -482.00K | 40.00K |
| Shares Outstanding (Basic) | 37.81M | 37.36M | 37.40M | 36.25M | 35.10M | 9.42M |
| Shares Outstanding (Diluted) | 37.81M | 37.36M | 37.40M | 36.25M | 35.10M | 9.42M |
| EPS (Basic) | -1.83 | -2.3 | -2.79 | -1.99 | -0.85 | -1.23 |
| EPS (Diluted) | -1.83 | -2.3 | -2.79 | -1.99 | -0.85 | -1.23 |
| EBITDA | -74.34M | -88.66M | -91.59M | -48.57M | -30.63M | -11.33M |
| Depreciation & Amortization | 1.85M | 4.89M | 3.67M | 2.50M | 1.33M | 302.00K |